Products Research Area/Disease Metabolism CircuLex Mouse FABP4/A-FABP ELISA Kit

CircuLex Mouse FABP4/A-FABP ELISA Kit

CircuLex Mouse FABP4/A-FABP ELISA Kit.

Specifications:

Components

Microplate
10X Wash Buffer
Dilution Buffer
Mouse FABP4/A-FABP Standard
HRP conjugated Detection Antibody
Substrate Reagent
Stop Solution

Description

The CircuLex Research Product Mouse FABP4/AFABP ELISA Kit is used for the quantitative measurement of mouse FABP4/AFABP in serum, plasma, tissue culture medium and other biological media. It can be used for 96 Assays.

Target:	FABP4/AFABP
Product Type:	ELISA Kit
Size:	96 Assays
Application:	ELISA
Research Area / Disease:	Metabolism
Sensitivity:	better than 34.4 pg/ml of sample.
Measurement Range:	Results exceeding FABP4/AFABP level of 1,000 ng/ml should be repeated with diluted samples. Dilution factors need to be taken into consideration in calculating the FABP4/AFABP concentration.
Regulatory Statement:	For Research Use Only. Not for use in diagnostic procedures.

Citations

Saint-Geniez M et al. Fatty acid binding protein 4 deficiency protects against oxygen-induced retinopathy in mice. PLoS One. 9, e96253 (2014),
Wu LE et al. Identification of fatty acid binding protein 4 as an adipokine that regulates insulin secretion during obesity. Mol Metab. 3, 465-73 (2014)

References

Makowski L, Hotamisligil GS. J Nutr (2004) 134: 2464S–8S.
Boord JB, Fazio S, Linton MF. Curr Opin Lipidol (2002) 13: 141–7.
Uysal KT, Scheja L, Wiesbrock SM, Bonner-Weir S, Hotamisligil GS. Endocrinology (2000) 141: 3388–96.
Hotamisligil GS, Johnson RS, Distel RJ, Ellis R, Papaioannou VE, Spiegelman BM. Science (1996) 274: 1377–9.
Coe NR, Simpson MA, Bernlohr DA. J Lipid Res (1999) 40: 967–72.
Scheja L, Makowski L, Uysal KT et al. Diabetes (1999) 48: 1987–94.
Baar RA, Dingfelder CS, Smith LA, Bernlohr DA, Wu C, Lange AJ, et al. Biochem Biophys Res Commun (1999) 261: 456–8.
Kazemi MR, McDonald CM, Shigenaga JK, Grunfeld C, Feingold KR. Arterioscler Thromb Vasc Biol (2005) 25: 1220–4.
Fu Y, Luo N, Lopes-Virella MF. J Lipid Res. (2000) 41: 2017–23.11. Llaverias G, Noe V, Penuelas S, Vazquez-Carrera M, Sanchez RM, Laguna JC, et al. Biochem Biophys Res Commun (2004) 318: 265–74.
Makowski L, Brittingham KC, Reynolds JM, Suttles J, Hotamisligil GS. J Biol Chem (2005) 280: 12888–95.
Makowski L, Boord JB, Maeda K, Babaev VR, Uysal KT, Morgan MA, et al. Nat Med (2001) 7: 699–705.
Boord JB, Maeda K, Makowski L, Babaev VR, Fazio S, Linton MF, et al. Circulation (2004) 110: 1492–8.
M Furuhashi, G Tuncman, CZ Gorgun, L Makowski, G Atsumi, E Vaillancourt, K Kono, VR Babaev, S Fazio, MF Linton, R Sulsky, JA Robl, RA Parker, and GS Hotamisligil. Nature (2007) 447: 959-65.